Unexpected Trends Boost Enrollment in Tobacco Cessation Trial,โข Offering Hope for More Diverse Clinical Research
Barcelona, Spain – September 6, 2025 – โA new subanalysis of the Screen ASSIST tobacco cessation clinical trial (NCT03611881) is challenging conventional wisdom about clinical trial participation,โ revealing surprisingly higher โข enrollment rates among โgroups historically underrepresented in research. The findings, presented this week at the World Conferenceโฃ on Lung cancer, suggest a pathway to improving diversity in clinical trials and ultimately reducing health disparities in lung cancer and other smoking-related illnesses.
The Screen ASSIST trial integrated tobacco cessation support intoโ a lung cancer screening program, offering counseling andโข nicotine replacement therapy โalongside connections to vital social resources. Researchers assessed โขenrollment patterns,